# A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

> **NCT06019507** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **ITB-Med LLC** · enrollment: 12 (estimated)

## Conditions studied

- Liver Transplantation

## Interventions

- **BIOLOGICAL:** TCD601
- **BIOLOGICAL:** Cyclophosphamide
- **DRUG:** TAC
- **DRUG:** MMF
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT06019507
- **Lead sponsor:** ITB-Med LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-29
- **Primary completion:** 2026-06
- **Final completion:** 2029-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019507, "A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06019507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*